2-201491791-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001168221.2(C2CD6):​c.4550G>T​(p.Trp1517Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000703 in 1,536,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

C2CD6
NM_001168221.2 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0620
Variant links:
Genes affected
C2CD6 (HGNC:14438): (C2 calcium dependent domain containing 6) An autosomal recessive form of juvenile amyotrophic lateral sclerosis was originally mapped to a region of chromosome 2 that includes this gene. The encoded protein contains a calcium-dependent membrane targeting C2 domain. This domain is often found in proteins that are involved in membrane trafficking and signal transduction. [provided by RefSeq, Jun 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.103414625).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C2CD6NM_001168221.2 linkc.4550G>T p.Trp1517Leu missense_variant Exon 15 of 16 ENST00000439140.6 NP_001161693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C2CD6ENST00000439140.6 linkc.4550G>T p.Trp1517Leu missense_variant Exon 15 of 16 1 NM_001168221.2 ENSP00000409937.1 Q53TS8-4
C2CD6ENST00000286195.7 linkc.1582-3889G>T intron_variant Intron 14 of 14 1 ENSP00000286195.3 Q53TS8-1
C2CD6ENST00000439802.5 linkc.*50-3889G>T intron_variant Intron 12 of 12 2 ENSP00000400672.1 Q53TS8-2
C2CD6ENST00000482942.1 linkn.101-3889G>T intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152142
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000562
AC:
8
AN:
142346
Hom.:
0
AF XY:
0.000105
AC XY:
8
AN XY:
76094
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000143
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000729
AC:
101
AN:
1384782
Hom.:
0
Cov.:
33
AF XY:
0.0000717
AC XY:
49
AN XY:
683318
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000856
Gnomad4 NFE exome
AF:
0.0000881
Gnomad4 OTH exome
AF:
0.0000518
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152142
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74314
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000302
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 27, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.4550G>T (p.W1517L) alteration is located in exon 15 (coding exon 15) of the ALS2CR11 gene. This alteration results from a G to T substitution at nucleotide position 4550, causing the tryptophan (W) at amino acid position 1517 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
13
DANN
Benign
0.96
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.44
T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-1.1
T
PrimateAI
Benign
0.33
T
PROVEAN
Benign
0.20
N
REVEL
Benign
0.020
Sift
Benign
0.21
T
Sift4G
Benign
0.67
T
Vest4
0.32
MutPred
0.50
Gain of helix (P = 0.0225);
MVP
0.18
MPC
0.26
ClinPred
0.048
T
GERP RS
1.5
gMVP
0.057

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs766972512; hg19: chr2-202356514; API